MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells

Tumours manage to survive the ablation of mutant KRAS, despite the development of KRAS-targeted drugs. Here we describe that inhibition of mutant KRAS promotes MEK nuclear localization as an alternative mechanism of KRAS-targeted drugs resistance. Tissue microarray analysis in colon tumours shows th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Death Differ
Autors principals: Xu, Huanji, Zhou, Sheng, Xia, Hongwei, Yu, Huangfei, Tang, Qiulin, Bi, Feng
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6889282/
https://ncbi.nlm.nih.gov/pubmed/30833665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41418-019-0309-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars